Melanie Demes Ursula Pession Jan Jeroch Falko Schulze Katrin Eichler Daniel Martin Peter Wild Oliver Waidmann
10.18632/oncotarget.28274
Oncotarget
2022 Sep 14;13:1034-1042.
anal cancer high-throughput nucleotide sequencing immunotherapy microsatellite instability nivolumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36128324/
Anus Neoplasms / drug therapy Anus Neoplasms / genetics HIV Infections Papillomavirus Infections
Anus Neoplasms / drug therapy Anus Neoplasms / genetics HIV Infections Papillomavirus Infections Case Reports Carboplatin Humans Microsatellite Instability MutL Protein Homolog 1 / genetics Mutation Nivolumab / therapeutic use Paclitaxel Programmed Cell Death 1 Receptor MLH1 protein, human Programmed Cell Death 1 Receptor Nivolumab Carboplatin MutL Protein Homolog 1 Paclitaxel Anal Canal Carcinoma
PMC9477220
36128324
Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation
2022